Correction to: Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Treatment and Pharmacology · Colorectal Cancer Treatments and Studies · Cancer survivorship and care
This is a correction to: Kai-Yuan Hsiao, Hsin-Pao Chen, Kun-Ming Rau, Kuang-Wen Liu, Ben-Chang Shia, Wei-Shan Chang, Hao-Yun Liang, Meng-Che Hsieh, Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib, The Oncologist, Volume 29, Issue 12, December 2024, Pages e1669–e1679, https://doi.org/10.1093/oncolo/oyae235
In the originally published version of the manuscript, there was an error in text in the Methods section. Under heading Data source, in the last sentence, the IRB number should read: “...,[...]” instead of: “...,[...]”.
The emendation has been made to the article.